M4MM
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
Oregon Invites Input on Psilocybin Service Center Regulations Through New Advisory Panel
SALEM – State health officials in Oregon are seeking participants for a rules advisory committee that will shape permanent guidelines on the temporary use of licensed Psilocybin Service Centers, as applications close in less than ...
California Enacts Law Requiring Intoxicating Hemp Sales Through Licensed Cannabis Outlets
LOS ANGELES – Governor Gavin Newsom signed Assembly Bill 8 into law on Thursday, directing intoxicating hemp-derived products into California's tightly controlled Cannabis distribution system and barring their sale elsewhere. The measure addresses gaps in ...
Case Study: Better Data, Better Decisions: How Clean Inputs Strengthen Cannabis Strategy
LOS ANGELES- In a highly regulated and competitive industry like cannabis, data isn’t just numbers on a spreadsheet — it’s the foundation of effective decision-making. Yet many operators still struggle with messy, inconsistent, or incomplete ...
NY Cannabis Board Hits Equity Target With 57% of Licenses to Social Equity Holders
NEW YORK – New York regulators reported that social and economic equity applicants now control 57% of the state's adult-use Cannabis licenses, a figure that clears the program's initial benchmark and signals steady advancement in ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
Iowa Imposes Stricter Limits on Hemp-Derived THC Products
LOS ANGELES- Iowa Governor Kim Reynolds signed multiple bills into law on Friday, including House File 2605, which aims to close loopholes in state and federal hemp laws. This bill imposes new restrictions on hemp-derived ...
Cannabis Stocks Surge Following Biden’s Reclassification Announcement
NEW YORK- At 1 p.m. on May 16, Biden shared a video on X, declaring the U.S. Department of Justice's decision to reclassify cannabis. This announcement led to a swift increase in cannabis-related stocks, reflecting ...
Cresco Labs Reports First Quarter Financial Performance
LOS ANGELES- Cresco Labs reported first-quarter revenues of $184 million, reflecting the company’s growth trajectory in the competitive cannabis market. This increase in revenue is attributed to market expansion and enhanced product offerings under its ...
DEA Report Highlights Shifts in U.S. Drug Trafficking Trends
LOS ANGELES- The Drug Enforcement Administration (DEA) released its 2024 National Drug Threat Assessment (NDTA) on May 9, providing an in-depth analysis of illegal drug and trafficking trends in the United States. DEA Administrator Anne ...
Canopy Growth Raises $50 Million Through Exchange and Subscription Agreement
LOS ANGELES- Canopy Growth, a cannabis producer based in Smiths Falls, Ontario, has raised approximately $50 million (68 million Canadian dollars) in gross proceeds through an exchange and subscription agreement with an institutional investor. The ...
DEA Report Highlights Growing Threat from Synthetic Drugs and Illegal Cannabis Operations
LOS ANGELES- The Drug Enforcement Administration (DEA) released its 2024 National Drug Threat Assessment (NDTA) on May 9, detailing illegal drug and trafficking trends in the United States. DEA Administrator Anne Milgram emphasized the shift ...
47 Ohio Municipalities Ban Adult-Use Cannabis Businesses Ahead of Program Launch
LOS ANGELES- As Ohio prepares for the launch of its adult-use cannabis program, several dozen municipalities have implemented temporary bans on adult-use cannabis businesses. Research from Ohio State University, summarized by Cleveland.com, indicates that as ...
Analysis: Adult-Use Cannabis Markets Generate Over $20 Billion in State Tax Revenue
Washington, DC (NORML): Taxes derived from the licensed sale of state-regulated cannabis products totaled more than $4 billion in 2023, according to an analysis provided by the Marijuana Policy Project. MPP’s estimates do not include revenues derived from ...
Biden Administration Begins Formal Rulemaking Process Downgrading Cannabis to Less Dangerous Drug
WASHINGTON, D.C. - President Joe Biden is officially advancing plans to ease federal cannabis restrictions. Today, Biden announced his administration's intention to reclassify cannabis from the most restrictive category on the federal list of illegal ...
Ohio Committee Approves Plan for Adult-Use Cannabis Sales
LOS ANGELES- The Ohio Joint Committee on Agency Rule Review (JCARR) has approved new regulations to allow medical cannabis dispensaries to sell adult-use products starting June 7, 2024. This development follows the voter approval of ...
Texas Senate to Hold Public Hearing on Delta-8, Delta-9 THC Products
LOS ANGELES- The Texas Senate will hold a public hearing on May 29 to discuss a potential ban on delta-8 and delta-9 THC products. These products have been widely available in Texas since 2019, following ...
Study Finds Psilocybin Use Does Not Significantly Alter Religious Beliefs
LOS ANGELES- A new study from Johns Hopkins University, published in the Journal of Psychoactive Drugs, indicates that a single psilocybin experience is unlikely to change an atheist's belief in God or alter a person's ...
Federal Judge Orders Cannabis Dispensary Operator to Bargain with Union
LOS ANGELES- In a landmark decision, U.S. District Judge Myong Joun has mandated that the cannabis dispensary operator I.N.S.A. must negotiate with the United Food and Commercial Workers (UFCW) union, despite its employees voting against ...
Enveric Biosciences Eyes Major Licensing Deals for Its Drug Pipeline
NEW YORK- Enveric Biosciences is actively pursuing licensing agreements that could potentially net the company up to $410 million in milestone payments. This initiative follows a newly announced partnership with MindBio and comes amidst the ...
New York Cannabis Regulatory Chief to Resign Amid Program Overhaul
LOS ANGELES- Chris Alexander, the Executive Director of New York's Office of Cannabis Management (OCM), is set to resign at the end of his three-year term in September, as announced by Governor Kathy Hochul. The ...
